Literature DB >> 9487227

Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response.

C A Morton, R M MacKie, C Whitehurst, J V Moore, J H McColl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9487227     DOI： 10.1001/archderm.134.2.248

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  13 in total

1.  Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: A nationwide retrospective study of 150 consecutive applications.

Authors:  Werner Dolak; Hubert Schwaighofer; Brigitte Hellmich; Bernhard Stadler; Georg Spaun; Wolfgang Plieschnegger; Arnold Hebenstreit; Jutta Weber-Eibel; Franz Siebert; Klaus Emmanuel; Peter Knoflach; Michael Gschwantler; Wolfgang Vogel; Michael Trauner; Andreas Püspök
Journal:  United European Gastroenterol J       Date:  2016-07-07       Impact factor: 4.623

2.  Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.

Authors:  Maria Bernadete Riemma Pierre; Eduardo Ricci; Antonio Cláudio Tedesco; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

3.  A light emitting diode (LED) based spatial frequency domain imaging system for optimization of photodynamic therapy of nonmelanoma skin cancer: quantitative reflectance imaging.

Authors:  R B Saager; D J Cuccia; S Saggese; K M Kelly; A J Durkin
Journal:  Lasers Surg Med       Date:  2013-04       Impact factor: 4.025

4.  Intracellular ZnO Nanorods Conjugated with Protoporphyrin for Local Mediated Photochemistry and Efficient Treatment of Single Cancer Cell.

Authors:  S Kishwar; M H Asif; O Nur; M Willander; Per-Olof Larsson
Journal:  Nanoscale Res Lett       Date:  2010-07-15       Impact factor: 4.703

5.  Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias.

Authors:  Paul A McCarron; Ryan F Donnelly; A David Woolfson
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

Review 6.  Pharmacological treatments for basal cell carcinoma.

Authors:  Seongmu Lee; Dinesh Selva; Shyamala C Huilgol; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study.

Authors:  Edward V Maytin; Urvashi Kaw; Muneeb Ilyas; Judith A Mack; Bo Hu
Journal:  Photodiagnosis Photodyn Ther       Date:  2018-02-19       Impact factor: 3.631

8.  Photodynamic therapy using systemic administration of 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode for methicillin-resistant Staphylococcus aureus-infected ulcers in mice.

Authors:  Kuniyuki Morimoto; Toshiyuki Ozawa; Kunio Awazu; Nobuhisa Ito; Norihiro Honda; Sohkichi Matsumoto; Daisuke Tsuruta
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

9.  Derivatives of 5-aminolevulinic Acid for photodynamic therapy.

Authors:  Ryan F Donnelly; Paul A McCarron; A David Woolfson
Journal:  Perspect Medicin Chem       Date:  2007-12-11

10.  Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.

Authors:  Ana Luiza Ribeiro de Souza; Kayla Marra; Jason Gunn; Kimberley S Samkoe; Stephen Chad Kanick; Scott C Davis; M Shane Chapman; Edward V Maytin; Tayyaba Hasan; Brian W Pogue
Journal:  Br J Cancer       Date:  2016-08-30       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.